2022
DOI: 10.1002/adma.202109661
|View full text |Cite
|
Sign up to set email alerts
|

Rapid Screen for Antiviral T‐Cell Immunity with Nanowire Electrochemical Biosensors

Abstract: comparisons was calculated using unpaired t-test or two-way analysis of variance (ANOVA). Plots and histograms were created and analyzed in Prism (Prism v.9.3.1, GraphPad)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(4 citation statements)
references
References 56 publications
(75 reference statements)
0
4
0
Order By: Relevance
“…This approach also holds promise for monitoring inflammatory responses in IBD. 51 Consequently, by combining different types of NWs with appropriate diagnostic technologies, significant advancements can be made in GI disease imaging, leading to improved diagnostic outcomes.…”
Section: Key Nps In Gi Diseases Imagingmentioning
confidence: 99%
“…This approach also holds promise for monitoring inflammatory responses in IBD. 51 Consequently, by combining different types of NWs with appropriate diagnostic technologies, significant advancements can be made in GI disease imaging, leading to improved diagnostic outcomes.…”
Section: Key Nps In Gi Diseases Imagingmentioning
confidence: 99%
“…Such an initiative is especially crucial in times like the pandemic, where there is an incentive for the rapid development of novel tools to quantify cellular immunity. For example, a recently described nanowire-based assay that promises rapid and accurate T cell quantification( Nami et al, 2022 ) or a skin test (similar to the tuberculin skin test) that has just received the greenlight to proceed with in-human trials (NCT05216510). This pandemic has also shown a lack of consensus among scientists and public health officers as to the best method of surveilling cellular immunity, unlike seroprevalence that was immediately monitored by the CDC.…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%
“…The development of this technology has had a profound impact on diabetes management. 11 Unlike the rst generation, the second generation of biosensors (microbial, 12,13 immune, 14,15 enzyme immune and organelle sensors 16,17 ) consists of biomarkers adsorbed or covalently bound to the surface of the transducer. In contrast, the third generation of biosensors, which are currently being developed, are those in which biomarkers are directly immobilized to electronic components, thus bringing together biometric and electrical signal processing, i.e., eld-effect biosensors that combine system biotechnology and electronics.…”
Section: Introductionmentioning
confidence: 99%